Cargando…

COVID-19 Control: Can Germany Learn From China?

The coronavirus disease 2019 (COVID-19) outbreak started in China in December 2019 and has developed into a pandemic. Using mandatory large-scale public health interventions including a lockdown with locally varying intensity and duration, China has been successful in controlling the epidemic at an...

Descripción completa

Detalles Bibliográficos
Autores principales: Müller, Olaf, Lu, Guangyu, Jahn, Albrecht, Razum, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kerman University of Medical Sciences 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719213/
https://www.ncbi.nlm.nih.gov/pubmed/32610735
http://dx.doi.org/10.34172/ijhpm.2020.78
_version_ 1783619633750736896
author Müller, Olaf
Lu, Guangyu
Jahn, Albrecht
Razum, Oliver
author_facet Müller, Olaf
Lu, Guangyu
Jahn, Albrecht
Razum, Oliver
author_sort Müller, Olaf
collection PubMed
description The coronavirus disease 2019 (COVID-19) outbreak started in China in December 2019 and has developed into a pandemic. Using mandatory large-scale public health interventions including a lockdown with locally varying intensity and duration, China has been successful in controlling the epidemic at an early stage. The epicentre of the pandemic has since shifted to Europe and The Americas. In certain cities and regions, health systems became overwhelmed by high numbers of cases and deaths, whereas other regions continue to experience low incidence rates. Still, lockdowns were usually implemented country-wide, albeit with differing intensities between countries. Compared to its neighbours, Germany has managed to keep the epidemic relatively well under control, in spite of a lockdown that was only partial. In analogy to many countries at a similar stage, Germany is now under increasing pressure to further relax lockdown measures to limit economic and psychosocial costs. However, if this is done too rapidly, Germany risks facing tens of thousands more severe cases of COVID-19 and deaths in the coming months. Hence, it could again follow China’s example and relax measures according to local incidence, based on intensive testing.
format Online
Article
Text
id pubmed-7719213
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Kerman University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-77192132020-12-09 COVID-19 Control: Can Germany Learn From China? Müller, Olaf Lu, Guangyu Jahn, Albrecht Razum, Oliver Int J Health Policy Manag Perspective The coronavirus disease 2019 (COVID-19) outbreak started in China in December 2019 and has developed into a pandemic. Using mandatory large-scale public health interventions including a lockdown with locally varying intensity and duration, China has been successful in controlling the epidemic at an early stage. The epicentre of the pandemic has since shifted to Europe and The Americas. In certain cities and regions, health systems became overwhelmed by high numbers of cases and deaths, whereas other regions continue to experience low incidence rates. Still, lockdowns were usually implemented country-wide, albeit with differing intensities between countries. Compared to its neighbours, Germany has managed to keep the epidemic relatively well under control, in spite of a lockdown that was only partial. In analogy to many countries at a similar stage, Germany is now under increasing pressure to further relax lockdown measures to limit economic and psychosocial costs. However, if this is done too rapidly, Germany risks facing tens of thousands more severe cases of COVID-19 and deaths in the coming months. Hence, it could again follow China’s example and relax measures according to local incidence, based on intensive testing. Kerman University of Medical Sciences 2020-05-27 /pmc/articles/PMC7719213/ /pubmed/32610735 http://dx.doi.org/10.34172/ijhpm.2020.78 Text en © 2020 The Author(s); Published by Kerman University of Medical Sciences This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Perspective
Müller, Olaf
Lu, Guangyu
Jahn, Albrecht
Razum, Oliver
COVID-19 Control: Can Germany Learn From China?
title COVID-19 Control: Can Germany Learn From China?
title_full COVID-19 Control: Can Germany Learn From China?
title_fullStr COVID-19 Control: Can Germany Learn From China?
title_full_unstemmed COVID-19 Control: Can Germany Learn From China?
title_short COVID-19 Control: Can Germany Learn From China?
title_sort covid-19 control: can germany learn from china?
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719213/
https://www.ncbi.nlm.nih.gov/pubmed/32610735
http://dx.doi.org/10.34172/ijhpm.2020.78
work_keys_str_mv AT mullerolaf covid19controlcangermanylearnfromchina
AT luguangyu covid19controlcangermanylearnfromchina
AT jahnalbrecht covid19controlcangermanylearnfromchina
AT razumoliver covid19controlcangermanylearnfromchina